Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Novogen Acquires Anti-Tropomyosins Drug Technology From Genscreen 12
Partnerships 14
Kazia Therapeutics Enters into Partnership with Dana-Farber Cancer Institute 14
Kazia Therapeutics Enters into Co-Development Agreement with St Jude Children’s Research Hospital 15
Noxopharm Enters into Agreement with Kazia Therapeutics 16
Novogen Enters into Contract Research Agreement with Novotech 17
Novogen to Enter into Co-Development Agreement with Feinstein Institute for Medical Research for Brain Cancer 18
Novogen Enters into Agreement with Genea Biocells 19
Novogen Forms Joint Venture With Yale University 20
Novogen Enters Into Agreement With The Ingham Institute For Applied Medical Research 22
Licensing Agreements 23
Heaton-Brown Life Sciences Enters into Licensing Agreement with Novogen 23
Novogen Enters into Licensing Agreement with Genentech for GDC-0084 24
Equity Offering 25
Kazia Therapeutics Raises USD0.6 Million in Share Purchase Plan 25
Kazia Therapeutics Raises USD2.4 Million in Private Placement of Shares 26
Kazia Therapeutics Files Registration Statement for Public Offering of American Depositary Shares and Warrants for up to USD100 Million 28
Novogen Raises USD13 Million in Rights Offering of Shares 29
Novogen to Raise USD0.51 Million in Private Placement of Shares 31
Novogen Raises USD12 Million in Private Placement of Shares 32
Novogen to Raise Additional USD1.4 million in Private Placement of Shares 33
Novogen Raises USD1.6 Million in Private Placement of Shares 35
Novogen Completes Second Tranche Of Private Placement Of Shares For US$0.14 Million 36
Novogen Completes Rights Offering Of Shares For US$0.8 Million 37
Novogen Completes Private Placement Of Shares For US$2 Million 38
Debt Offering 39
Novogen Completes Third Tranche of Private Placement Of Private Placement Of Note For US$3.7 Million 39
Asset Transactions 40
TroBio Therapeutics Acquires ATM Program from Kazia Therapeutics 40
TR Therapeutics Completes Acquisition Of Glucan Technology Assets From Novogen 41
Acquisition 42
Novogen Acquires Glioblast for USD1.6 Million 42
Novogen Completes Acquisition Of Triaxial Pharma For US$2 Million 43
Kazia Therapeutics Ltd – Key Competitors 44
Kazia Therapeutics Ltd – Key Employees 45
Kazia Therapeutics Ltd – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Recent Developments 47
Financial Announcements 47
Aug 29, 2017: Novogen Annual Report And Full-year Financial Results 47
Corporate Communications 49
Jun 08, 2017: Novogen Streamlines Board and Costs 49
Mar 10, 2017: Novogen Announces Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure 50
Mar 10, 2017: Novogen: Transformation To A Clinical Stage Organisation Leads To Changes In Management Structure 51
Product News 52
05/07/2018: Emerging oncology researcher says women lose out as ovarian cancer treatments lag 52
Clinical Trials 53
Sep 13, 2018: Australian clinical trial of ovarian cancer therapy Cantrixil pivotal for cancer stem cell research 53
Jun 19, 2018: Kazia Releases Preliminary Cantrixil Phase I Data 54
Aug 07, 2017: Progress Update on Cantrixil (TRXE-002-1) Development 55
Other Significant Developments 57
Feb 19, 2018: Kazia Change Of Registered Office And Business Address 57
Aug 14, 2017: Novogen: Board Review Of Business Operations And Governance 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Kazia Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Novogen Acquires Anti-Tropomyosins Drug Technology From Genscreen 12
Kazia Therapeutics Enters into Partnership with Dana-Farber Cancer Institute 14
Kazia Therapeutics Enters into Co-Development Agreement with St Jude Children’s Research Hospital 15
Noxopharm Enters into Agreement with Kazia Therapeutics 16
Novogen Enters into Contract Research Agreement with Novotech 17
Novogen to Enter into Co-Development Agreement with Feinstein Institute for Medical Research for Brain Cancer 18
Novogen Enters into Agreement with Genea Biocells 19
Novogen Forms Joint Venture With Yale University 20
Novogen Enters Into Agreement With The Ingham Institute For Applied Medical Research 22
Heaton-Brown Life Sciences Enters into Licensing Agreement with Novogen 23
Novogen Enters into Licensing Agreement with Genentech for GDC-0084 24
Kazia Therapeutics Raises USD0.6 Million in Share Purchase Plan 25
Kazia Therapeutics Raises USD2.4 Million in Private Placement of Shares 26
Kazia Therapeutics Files Registration Statement for Public Offering of American Depositary Shares and Warrants for up to USD100 Million 28
Novogen Raises USD13 Million in Rights Offering of Shares 29
Novogen to Raise USD0.51 Million in Private Placement of Shares 31
Novogen Raises USD12 Million in Private Placement of Shares 32
Novogen to Raise Additional USD1.4 million in Private Placement of Shares 33
Novogen Raises USD1.6 Million in Private Placement of Shares 35
Novogen Completes Second Tranche Of Private Placement Of Shares For US$0.14 Million 36
Novogen Completes Rights Offering Of Shares For US$0.8 Million 37
Novogen Completes Private Placement Of Shares For US$2 Million 38
Novogen Completes Third Tranche of Private Placement Of Private Placement Of Note For US$3.7 Million 39
TroBio Therapeutics Acquires ATM Program from Kazia Therapeutics 40
TR Therapeutics Completes Acquisition Of Glucan Technology Assets From Novogen 41
Novogen Acquires Glioblast for USD1.6 Million 42
Novogen Completes Acquisition Of Triaxial Pharma For US$2 Million 43
Kazia Therapeutics Ltd, Key Competitors 44
Kazia Therapeutics Ltd, Key Employees 45
Kazia Therapeutics Ltd, Subsidiaries 46
List of Figures
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9